T cell immunity to seasonal Influenza A and H5N1 viruses in laboratory workers receiving annual seasonal Influenza vaccines
Open Access
- 18 December 2025
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 16, 1718805
Abstract
Background: Emerging threats such as highly pathogenic influenza strains like H5N1 emphasize the need for vaccines that induce cross-reactive immunity against conserved epitopes. Existing influenza vaccines primarily elicit strain-specific responses, leaving gaps in protection against pandemic subtypes. This study aimed to evaluate T cell responses to seasonal influenza A and H5N1 and compare them to SARS-CoV-2 specific T cell responses to understand differences shaped by distinct exposure histories and vaccination strategies. Methods: T cell responses were assessed in 41 laboratory workers who received annual seasonal influenza vaccines using ELISpot to quantify responses to peptide pools derived from influenza (H1N1 hemagglutinin [HA], H3N2 HA, H5N1 HA, matrix protein 1 [MP1], nucleoprotein [NP]) and SARS-CoV-2 (spike [S2S], nucleocapsid [S2N]). Ten-day expansion assays were used to evaluate functional cross-reactivity between H1, H3, and H5 HA. Intracellular cytokine staining was performed to assess antigen-specific T cell functionality. We used the IFN-γ ELISpot assay and intracellular cytokine staining to evaluate T cell responses to H5N1 HA peptides and assessed cross-reactivity and functional similarity in H1N1 HA-expanded cells. Results: The percentage of individuals with effector T cell responses to influenza peptide pools, was markedly lower than the percentage of individuals with S2S-specific T cells. However, HA-specific memory cells that cross-recognized H1, H3, and H5 HA were present in many individuals. T cells expanded with H1 or H5 HA proteins cross-recognized homologous epitopes in the 2 proteins and cytokine production profiles were comparable between H1- and H5-expanded T cells. Conclusion: These results highlight the potential for influenza vaccines to elicit cross-reactive immunity against H5N1 viruses. These findings also demonstrate differences between T cell responses to influenza and SARS-CoV-2, highlighting distinct immune profiles that could inform future vaccine strategies.Keywords
This publication has 47 references indexed in Scilit:
- CD8+ T cell epitope conservation in emerging H5N1 viruses suggests global protectionClinical & Translational Immunology, 2024
- SARS-CoV-2 Vaccines and the Growing Threat of Viral VariantsJAMA, 2021
- Adaptive immunity to SARS-CoV-2 and COVID-19Cell, 2021
- T cell immunity to SARS-CoV-2 following natural infection and vaccinationBiochemical and Biophysical Research Communications, 2021
- COVID-19 and the Path to ImmunityJAMA, 2020
- Immunology of COVID-19: Current State of the ScienceImmunity, 2020
- Influenza virus-specific CD4+ and CD8+ T cell-mediated immunity induced by infection and vaccinationJournal of Clinical Virology, 2019
- Immunity to seasonal and pandemic influenza A virusesMicrobes and Infection, 2011
- Genome-wide screening of human T-cell epitopes in influenza A virus reveals a broad spectrum of CD4+ T-cell responses to internal proteins, hemagglutinins, and neuraminidasesHuman Immunology, 2009
- Antigenic Cross-Reactivity Among H5N1 Viruses2009